DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,694,223 | +2.0% | 180,146 | -1.4% | 0.29% | +6.6% |
| Q2 2023 | $43,835,040 | -3.4% | 182,646 | +1.4% | 0.27% | -9.1% |
| Q1 2023 | $45,378,794 | -4.0% | 180,046 | +1.1% | 0.30% | -9.4% |
| Q4 2022 | $47,256,969 | +3.3% | 178,046 | +0.5% | 0.33% | -2.1% |
| Q3 2022 | $45,755,000 | +3.4% | 177,146 | +1.5% | 0.34% | +10.9% |
| Q2 2022 | $44,251,000 | -6.0% | 174,546 | +8.7% | 0.30% | +11.4% |
| Q1 2022 | $47,093,000 | -10.6% | 160,546 | +0.3% | 0.27% | -1.4% |
| Q4 2021 | $52,687,000 | +8.5% | 160,138 | +0.4% | 0.28% | 0.0% |
| Q3 2021 | $48,570,000 | +13.4% | 159,538 | 0.0% | 0.28% | +10.0% |
| Q2 2021 | $42,814,000 | +19.6% | 159,538 | +0.3% | 0.25% | +11.1% |
| Q1 2021 | $35,796,000 | +1.4% | 159,038 | +0.1% | 0.23% | -6.2% |
| Q4 2020 | $35,306,000 | +1.8% | 158,938 | -1.4% | 0.24% | -12.7% |
| Q3 2020 | $34,698,000 | +22.1% | 161,138 | +0.2% | 0.28% | +10.8% |
| Q2 2020 | $28,423,000 | +40.2% | 160,738 | +9.7% | 0.25% | +11.2% |
| Q1 2020 | $20,272,000 | -14.5% | 146,467 | -5.2% | 0.22% | +14.3% |
| Q4 2019 | $23,723,000 | +7.0% | 154,567 | +0.7% | 0.20% | -2.5% |
| Q3 2019 | $22,165,000 | +2.8% | 153,467 | +1.7% | 0.20% | +3.1% |
| Q2 2019 | $21,562,000 | -9.8% | 150,867 | -16.7% | 0.20% | +1.6% |
| Q1 2019 | $23,904,000 | +31.3% | 181,067 | +2.5% | 0.19% | +17.8% |
| Q4 2018 | $18,208,000 | -8.7% | 176,567 | -3.8% | 0.16% | +11.6% |
| Q3 2018 | $19,936,000 | +11.0% | 183,467 | +0.8% | 0.15% | +2.8% |
| Q2 2018 | $17,957,000 | +1.5% | 181,967 | +0.7% | 0.14% | 0.0% |
| Q1 2018 | $17,699,000 | +6.2% | 180,767 | +0.7% | 0.14% | +8.4% |
| Q4 2017 | $16,658,000 | +4.7% | 179,467 | -3.2% | 0.13% | +1.6% |
| Q3 2017 | $15,909,000 | -64.0% | 185,467 | -64.6% | 0.13% | -61.4% |
| Q2 2017 | $44,218,000 | -1.3% | 523,967 | +0.1% | 0.33% | -3.5% |
| Q1 2017 | $44,781,000 | -4.9% | 523,567 | -13.4% | 0.35% | -7.5% |
| Q4 2016 | $47,081,000 | +20.0% | 604,847 | +20.9% | 0.37% | +21.0% |
| Q3 2016 | $39,224,000 | +76.5% | 500,371 | +127.5% | 0.31% | +77.6% |
| Q2 2016 | $22,217,000 | -2.0% | 219,971 | -8.0% | 0.17% | -3.3% |
| Q1 2016 | $22,669,000 | -49.6% | 238,971 | -50.6% | 0.18% | -47.7% |
| Q4 2015 | $44,972,000 | +46.1% | 484,191 | +34.1% | 0.34% | +44.5% |
| Q3 2015 | $30,777,000 | +50.6% | 361,191 | +51.3% | 0.24% | +67.6% |
| Q2 2015 | $20,438,000 | +1.6% | 238,791 | +0.8% | 0.14% | +0.7% |
| Q1 2015 | $20,112,000 | -6.8% | 236,891 | -5.9% | 0.14% | -1.4% |
| Q4 2014 | $21,581,000 | +13.7% | 251,791 | +0.8% | 0.14% | +8.3% |
| Q3 2014 | $18,987,000 | -2.2% | 249,891 | +1.4% | 0.13% | -2.9% |
| Q2 2014 | $19,406,000 | +5.5% | 246,491 | +0.5% | 0.14% | -1.4% |
| Q1 2014 | $18,389,000 | -2.3% | 245,191 | +0.6% | 0.14% | -4.2% |
| Q4 2013 | $18,821,000 | +11.6% | 243,791 | +0.2% | 0.14% | -2.7% |
| Q3 2013 | $16,865,000 | +12.8% | 243,291 | +3.0% | 0.15% | +8.0% |
| Q2 2013 | $14,957,000 | – | 236,291 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |